{"id":100,"date":"2017-12-07T19:45:54","date_gmt":"2017-12-07T19:45:54","guid":{"rendered":"http:\/\/labs.icahn.mssm.edu\/ishikawalab\/?page_id=100"},"modified":"2026-03-04T16:10:35","modified_gmt":"2026-03-04T16:10:35","slug":"grants-and-fundings","status":"publish","type":"page","link":"https:\/\/labs.icahn.mssm.edu\/ishikawalab\/grants-and-fundings\/","title":{"rendered":"Grants and Fundings"},"content":{"rendered":"<p><strong>ACTIVE \u00a0<\/strong><\/p>\n<ul>\n<li style=\"text-align: left\">NIH R01\u00a0 \u00a0 \u00a0HL139963\u00a0 (Ishikawa)\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 12\/15\/2017 &#8211; 11\/30\/2026\u00a0 \u00a0 \u00a0 \u00a0 \u00a0Percutaneous Left Ventricular Unloading for Cardiogenic Shock: Beyond Acute Hemodynamic Support \u00a0(renewed)<\/li>\n<li>NIH R01\u00a0 \u00a0 HL173593\u00a0 \u00a0 (Ishikawa)\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a004\/02\/2024 &#8211; 01\/31\/2029 \u00a0 \u00a0 \u00a0 Cardiac AAV gene delivery for clinical translation<\/li>\n<li style=\"text-align: left\">Abiomed\u00a0\u00a0 Inc. \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (Ishikawa)\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a003\/01\/2016 &#8211; 1\/18\/2028\u00a0 \u00a0 \u00a0 \u00a0 \u00a0Improving the gene transduction efficacy of intracoronary delivery using an Impella<\/li>\n<li>APT Therapeutics (Ishikawa)\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a001\/01\/2024- 04\/30\/2026\u00a0 \u00a0 \u00a0 \u00a0 Multi-functional Antithrombotic Therapy for Coronary Microvascular Obstruction (SBIR)<\/li>\n<li>NIH R61 HL163755 (Benza)\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a009\/01\/2023 \u2013 08\/31\/2026\u00a0 \u00a0 \u00a0The Development of a Biatrial Catheter for a Cardiopulmonary Support System in Pulmonary Arterial Hypertension (Co-I)<\/li>\n<li><a href=\"https:\/\/labs.icahn.mssm.edu\/ishikawalab\/c-arm-nih-s10od034330\/\">NIH S10 OD034330<\/a> (Ishikawa)\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a004\/01\/2023 &#8211; 03\/302028\u00a0 \u00a0 \u00a0 \u00a0 \u00a0Animal cathlab C-arm<\/li>\n<li>NIH NHLBI GTRP RSA 2035\u00a0 \u00a0(Ishikawa)\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0Preclinical Vector Production \u201cImproving Cardiac AAV Gene Transduction Using Intracoronary Delivery\u201d\n<ul>\n<li style=\"list-style-type: none\">\n<ul style=\"text-align: left\">\n<li style=\"list-style-type: none\"><!--more--><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p><strong>Completed\/Ended<\/strong><\/p>\n<ul>\n<li>Cardiac RSK3 inhibitors (Ishikawa)\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 06\/27\/2023 &#8211; 07\/31\/2025\u00a0 \u00a0 \u00a0 \u00a0 Targeting of mAKAP Signalosomes in a pig model of myocardial infarction (SBIR)<\/li>\n<li>NIH\u00a0 R01HL148786 (Sahoo)\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 07\/01\/2019 &#8211; 06\/30\/2025\u00a0 \u00a0 \u00a0 \u00a0AAV-Exosomes: Escaping Neutralizing Antibody and Enhancing Delivery\u00a0 (Co-I)<\/li>\n<li>Abiomed Inc\u00a0 \u00a0 \u00a0 \u00a0 (Ishikawa)\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a005\/18\/2022 \u2013 06\/30\/2024\u00a0 \u00a0 \u00a0 \u00a0Combination of LV mechanical unloading and hypothermia for infarct size reduction<\/li>\n<li>Nuevocor\u00a0 \u00a0(Ishikawa)\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a008\/01\/2022 \u2013 07\/31\/2023\u00a0 \u00a0 \u00a0 \u00a0Nuevocor-Sinai AAV gene therapy project: Clinically applicable AAV delivery methods for the heart<\/li>\n<li>NIH\/NHLBI\u00a0\u00a0\u00a01R01HL130423-01 (Ishikawa\/Kovacic) \u00a0 \u00a0 \u00a0 \u00a0 01\/25\/2016 &#8211; 12\/31\/2021\u00a0 \u00a0 \u00a0 \u00a0 \u00a0Toward Therapeutic Manipulation of Endothelial to Mesenchymal Transition.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Role (Co-PI)<\/li>\n<li>NIH\/NHLBI\u00a0\u00a01R01HL135093 (Fish\/Kovacic)\u00a0\u00a0\u00a0 12\/01\/2016 &#8211; 11\/30\/2021\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Therapeutic Mechanisms of Cardiac Progenitors in Ischemic Cardiomyopathy\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Role (Co-I)<\/li>\n<li>AHA-SDG \u00a0\u00a0\u00a0\u00a0\u00a017SDG33410873 \u00a0\u00a0\u00a0 (Ishikawa) \u00a0\u00a0 01\/01\/2017 &#8211; 12\/31\/2019\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Mechanistic and Therapeutic Roles of miRNAs in Left Ventricular Remodeling and Heart Failure\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Role (PI)<\/li>\n<li>NIH\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0R01HL131404 (Hajjar\/Weber)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0 \u00a0 \u00a0 07\/01\/2016 &#8211; 06\/30\/2020\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 Anti-AAV Antibodies as an Obstacle to Cardiac AAV Gene Therapy\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Role (Co-I)<\/li>\n<li>Cardiac RSK3 Inhibitors, LLC (Fish)\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 02\/06\/2019 &#8211; 02\/05\/2020\u00a0 \u00a0 \u00a0 \u00a0 \u00a0Gene Therapy for Cardiac Remodeling<\/li>\n<li>T32 Research Fellowship (Mazurek)\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 09\/22\/2020 &#8211; 09\/21\/2021<\/li>\n<li>Cardiac RSK3 inhibitors (Ishikawa)\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a09\/30\/2021-9\/29\/2022\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0AAV-RBD gene therapy in a pig model of myocardial infarction (PI)<\/li>\n<li>T32 Research Fellowship (Marvopoulos)\u00a0 \u00a0 \u00a0 \u00a0 \u00a006\/28\/2021 &#8211; 06\/27\/2024<\/li>\n<li>ACURE Research Fellowship Grant (Sakata)\u00a0 07\/01\/2021 &#8211; 06\/30\/2023<!--more--><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>ACTIVE \u00a0 NIH R01\u00a0 \u00a0 \u00a0HL139963\u00a0 (Ishikawa)\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 12\/15\/2017 &#8211; 11\/30\/2026\u00a0 \u00a0 \u00a0 \u00a0 \u00a0Percutaneous Left Ventricular Unloading for Cardiogenic Shock: Beyond Acute Hemodynamic Support \u00a0(renewed) NIH R01\u00a0 \u00a0 HL173593\u00a0 \u00a0 (Ishikawa)\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a004\/02\/2024 &#8211; 01\/31\/2029 \u00a0 \u00a0 \u00a0 Cardiac AAV gene delivery for clinical translation [&hellip;]<\/p>\n","protected":false},"author":246,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-100","page","type-page","status-publish","hentry"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/labs.icahn.mssm.edu\/ishikawalab\/wp-json\/wp\/v2\/pages\/100","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/labs.icahn.mssm.edu\/ishikawalab\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/labs.icahn.mssm.edu\/ishikawalab\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/labs.icahn.mssm.edu\/ishikawalab\/wp-json\/wp\/v2\/users\/246"}],"replies":[{"embeddable":true,"href":"https:\/\/labs.icahn.mssm.edu\/ishikawalab\/wp-json\/wp\/v2\/comments?post=100"}],"version-history":[{"count":32,"href":"https:\/\/labs.icahn.mssm.edu\/ishikawalab\/wp-json\/wp\/v2\/pages\/100\/revisions"}],"predecessor-version":[{"id":597,"href":"https:\/\/labs.icahn.mssm.edu\/ishikawalab\/wp-json\/wp\/v2\/pages\/100\/revisions\/597"}],"wp:attachment":[{"href":"https:\/\/labs.icahn.mssm.edu\/ishikawalab\/wp-json\/wp\/v2\/media?parent=100"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}